JOSEPH M PATTI Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSEPH M PATTI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSEPH M PATTI. JOSEPH M PATTI is CEO in Aviragen Therapeutics, Inc. ($NABI) and Director in Armata Pharmaceuticals, Inc. ($APHB) and Chief Scientific Officer in INHIBITEX, INC. ($INHX).
Latest Insider Trading Transactions of JOSEPH M PATTI
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APHB, INHX, VXRT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 09 2020 | APHB | Armata Pharmaceuti ... | PATTI JOSEPH M | Director | Option Exercise | A | 3.15 | 23,000 | 72,450 | 23,000 | |
| May 24 2019 | APHB | Armata Pharmaceuti ... | PATTI JOSEPH M | Director | Option Exercise | A | 3.15 | 27,383 | 86,256 | 27,383 | |
| Apr 05 2017 | AVIR | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Option Exercise | A | 0.66 | 650,000 | 426,400 | 2,113,304 | |
| Aug 12 2016 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Option Exercise | A | 1.30 | 380,000 | 494,000 | 1,478,929 | |
| Sep 28 2015 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Buy | P | 1.85 | 2,500 | 4,625 | 126,128 | 123.6 K to 126.1 K (+2.02 %) |
| Sep 28 2015 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Buy | P | 1.89 | 2,500 | 4,713 | 123,628 | 121.1 K to 123.6 K (+2.06 %) |
| Aug 13 2015 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Option Exercise | A | 2.49 | 250,000 | 622,500 | 250,000 | |
| Mar 31 2015 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Buy | P | 2.30 | 10,000 | 22,989 | 121,128 | 111.1 K to 121.1 K (+9.00 %) |
| Mar 31 2015 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Buy | P | 2.27 | 10,000 | 22,700 | 111,128 | 101.1 K to 111.1 K (+9.89 %) |
| Feb 22 2005 | INHX | INHIBITEX, INC. | PATTI JOSEPH M | Chief Scientific Of ... | Option Exercise | A | 9.07 | 92,500 | 838,975 | 92,500 |
Page: 1